Literature DB >> 20388468

[Real-world study: a potential new approach to effectiveness evaluation of traditional Chinese medicine interventions].

Feng Tian1, Yan-ming Xie.   

Abstract

Some conclusions drawn from explanatory randomized controlled trial (ERCT) lack practical value in application under real-world clinical settings, and there are also some limitations on the generalization of pragmatic randomized controlled trial (PRCT) results. In some countries, real-world studies (RWSs) have been conducted to explore the effectiveness and safety of clinical interventions or postmarketing drugs, which is a new tendency in clinical researches. By reviewing some RWSs carried out in Western countries, we sum up the basic characteristics of the research design, and discuss the differences and connections between PRCT and RWS. The design ideas of RWS are different from PRCT. Researchers in RWS tend to perform long-term evaluation based on large quantities of subjects and quite large sample and focus on outcome measures which are clinically meaningful. Strict control on data collection, management and analysis are very important to RWS and PRCT. Owing to the complexity of clinical interventions and evaluation, PRCT is not completely suitable for clinical researches in traditional Chinese medicine (TCM). It is an inevitable tendency to apply RWS in clinical trials of TCM. We can explore the efficacy of TCM interventions through PRCT, and better understand the effectiveness through RWS. RWS will become a powerful approach to TCM clinical trials and postmarketing evaluation of Chinese medicines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388468     DOI: 10.3736/jcim20100401

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  14 in total

Review 1.  Discussion of solutions to ethical issues in real-world study.

Authors:  Sicheng Wang; Baoyan Liu; Ningning Xiong; Qi Xie; Runshun Zhang; Xuezhong Zhou; Jie Qiao
Journal:  Front Med       Date:  2014-09-03       Impact factor: 4.592

2.  What can comparative effectiveness research, propensity score and registry study bring to Chinese medicine?

Authors:  Xing Liao; Yan-ming Xie
Journal:  Chin J Integr Med       Date:  2014-03-07       Impact factor: 1.978

3.  Effects of Yinzhihuang Granules on Serum Liver Enzymes in Jaundice Patients: A Real-World Study Based on HIS Data.

Authors:  Cheng Zhang; Lidan Zhang; Jian Lyu; Yanming Xie; Yuting Xie
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-05       Impact factor: 2.629

4.  Clinical and Economic Evaluation of Salvianolate Injection for Coronary Heart Disease: A Retrospective Study Based on National Health Insurance Data in China.

Authors:  Lisong Yang; Xiaolan Chen; Carolina Oi Lam Ung; He Zhu; Hao Hu; Sheng Han
Journal:  Front Pharmacol       Date:  2020-06-18       Impact factor: 5.810

Review 5.  Integrative Western and chinese medicine on coronary heart disease: where is the orientation?

Authors:  Siming Li; Hao Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-19       Impact factor: 2.629

Review 6.  Adaption and application of the four phase trials to traditional chinese medicines.

Authors:  M Y Di; J L Tang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-20       Impact factor: 2.629

7.  Real world evidence: experience and lessons from China.

Authors:  Xin Sun; Jing Tan; Li Tang; Jeff Jianfei Guo; Xinling Li
Journal:  BMJ       Date:  2018-02-05

8.  Reevaluation of the post-marketing safety of Shuxuening injection based on real-world and evidence-based evaluations.

Authors:  Can Wang; Qing-Ping Shi; Feng Ding; Xiao-Dong Jiang; Wei Tang; Mei-Ling Yu; Jian-Hua Zhu
Journal:  Drug Des Devel Ther       Date:  2018-04-05       Impact factor: 4.162

Review 9.  Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications.

Authors:  Zuanji Liang; Yunfeng Lai; Meng Li; Junnan Shi; Chi Ieong Lei; Hao Hu; Carolina Oi Lam Ung
Journal:  Chin Med       Date:  2021-02-16       Impact factor: 5.455

10.  Association Rule Analysis for Validating Interrelationships of Combined Medication of Compound Kushen Injection in Treating Colon Carcinoma: A Hospital Information System-Based Real-World Study.

Authors:  Huisheng Yang; Yanming Xie; Jisheng Ni; Yue Liu; Rui Song; Cen Chen; Yan Zhuang; Yin Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.